Casenas, Mariane Yhasie C.
HRN: 21-96-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/07/2022
10/14/2022
IV
350mg
Q6
PCAP -C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes